TAKARA BIO INC. Toevoegen aan een lijst
Financiën Takara Bio Inc. Deutsche Boerse AG
Aandelen
TF2
JP3460200003
Biotechnologie & Medisch Onderzoek
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 6,55 EUR | +0,77% |
|
+5,65% | -14,94% |
| 15/02 | Takara Bio's toerekenbare inkomen daalt met 98,9% in fiscale negen maanden | MT |
| 2023 | Takara Bio Inc. Herziet de geconsolideerde winstverwachting voor het jaar dat eindigt op 31 maart 2024 | CI |
Totale waarde
| Fiscaal tijdperk: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 268.647 | 357.394 | 269.851 | 208.680 | 116.803 | 141.609 | - | - |
| Bedrijfswaarde 1 | 249.501 | 332.542 | 247.265 | 157.805 | 82.355 | 141.609 | 141.609 | 141.609 |
| K/w-verhouding | 70,3 x | 37,4 x | 13,6 x | 13 x | 78,9 x | 38,7 x | 33,1 x | 28,2 x |
| Dividendrendement | 0,36% | 0,54% | 1,47% | 2,42% | 1,75% | 1,53% | 1,7% | 1,9% |
| Marktkapitalisatie/omzet | 7,77 x | 7,75 x | 3,99 x | 2,67 x | 2,68 x | 2,99 x | 2,8 x | 2,65 x |
| Bedrijfswaarde/omzet | 7,77 x | 7,75 x | 3,99 x | 2,67 x | 2,68 x | 2,99 x | 2,8 x | 2,65 x |
| Bedrijfswaarde/EBITDA | 27,7 x | 20,2 x | 8,19 x | 8,28 x | 14,7 x | 15,1 x | 13,6 x | 12,4 x |
| Bedrijfswaarde/FCF | 114 x | 35,2 x | -3.138 x | 6,91 x | -10,3 x | 17,7 x | 86,2 x | 45,2 x |
| FCF Yield | 0,88% | 2,84% | -0,03% | 14,5% | -9,7% | 5,65% | 1,16% | 2,21% |
| Price to Book | 4,04 x | 4,82 x | 2,81 x | 1,86 x | 1,05 x | 1,26 x | 1,25 x | 1,23 x |
| Aantal aandelen (in duizenden) | 120.416 | 120.416 | 120.416 | 120.416 | 120.416 | 120.416 | - | - |
| Referentieprijs 2 | 2.231 | 2.968 | 2.241 | 1.733 | 970,0 | 1.176 | 1.176 | 1.176 |
| Datum van publicatie | 14/05/20 | 13/05/21 | 12/05/22 | 11/05/23 | 10/05/24 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 34.565 | 46.086 | 67.699 | 78.142 | 43.505 | 47.412 | 50.546 | 53.407 |
| EBITDA 1 | 9.691 | 17.658 | 32.956 | 25.190 | 7.922 | 9.403 | 10.394 | 11.454 |
| Bedrijfsresultaat (EBIT) 1 | 6.274 | 13.952 | 28.902 | 20.541 | 3.003 | 5.070 | 5.946 | 6.936 |
| Operationele Marge | 18,15% | 30,27% | 42,69% | 26,29% | 6,9% | 10,69% | 11,76% | 12,99% |
| Resultaat voor belastingen (EBT) 1 | 5.433 | 13.552 | 27.532 | 21.224 | 2.853 | 5.066 | 5.963 | 6.978 |
| Nettowinst (verlies) 1 | 3.819 | 9.547 | 19.849 | 16.012 | 1.480 | 3.658 | 4.284 | 5.024 |
| Nettomarge | 11,05% | 20,72% | 29,32% | 20,49% | 3,4% | 7,72% | 8,47% | 9,41% |
| WPA 2 | 31,72 | 79,29 | 164,8 | 133,0 | 12,30 | 30,38 | 35,58 | 41,73 |
| Free Cash Flow 1 | 2.356 | 10.165 | -86 | 30.204 | -11.332 | 8.006 | 1.642 | 3.136 |
| FCF-marge | 6,82% | 22,06% | -0,13% | 38,65% | -26,05% | 16,89% | 3,25% | 5,87% |
| Kasstroomconversie (ebitda) | 24,31% | 57,57% | - | 119,9% | - | 85,14% | 15,8% | 27,37% |
| Kasstroomconversie (nettowinst) | 61,69% | 106,47% | - | 188,63% | - | 218,86% | 38,34% | 62,41% |
| Dividend per aandeel 2 | 8,000 | 16,00 | 33,00 | 42,00 | 17,00 | 18,00 | 20,00 | 22,33 |
| Datum van publicatie | 14/05/20 | 13/05/21 | 12/05/22 | 11/05/23 | 10/05/24 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: March | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 18.115 | 17.393 | 28.693 | 31.551 | 14.108 | 22.040 | 36.148 | 14.102 | 18.485 | 32.587 | 27.619 | 17.936 | 45.555 | 9.176 | 9.940 | 19.116 | 10.618 | 13.771 | 24.389 | 9.594 | 10.274 | 19.868 | 11.323 | 15.231 | 26.553 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 3.239 | 3.736 | - | 14.105 | 5.821 | 8.976 | 14.797 | 4.537 | 6.333 | 10.870 | 8.533 | 1.138 | 9.671 | 423 | 987 | 1.410 | -1.074 | 2.667 | 1.593 | -175 | 819 | 644 | 913 | 2.586 | 3.499 |
| Operationele Marge | 17,88% | 21,48% | - | 44,71% | 41,26% | 40,73% | 40,93% | 32,17% | 34,26% | 33,36% | 30,9% | 6,34% | 21,23% | 4,61% | 9,93% | 7,38% | -10,11% | 19,37% | 6,53% | -1,82% | 7,97% | 3,24% | 8,06% | 16,98% | 13,18% |
| Resultaat voor belastingen (EBT) 1 | 2.483 | 3.281 | - | 14.203 | 5.911 | 7.418 | 13.329 | 5.479 | 6.352 | 11.831 | 8.487 | 906 | 9.393 | 505 | 1.083 | 1.588 | -1.088 | 2.353 | 1.265 | -259 | 734 | 475 | 822 | 2.519 | 3.341 |
| Nettowinst (verlies) 1 | 1.744 | 2.274 | - | 10.009 | 4.355 | 5.485 | 9.840 | 3.907 | 4.631 | 8.538 | 6.057 | 1.417 | 7.474 | 319 | 765 | 1.084 | -930 | 1.326 | 396 | -539 | 454 | -85 | 542 | 2.239 | 2.781 |
| Nettomarge | 9,63% | 13,07% | - | 31,72% | 30,87% | 24,89% | 27,22% | 27,71% | 25,05% | 26,2% | 21,93% | 7,9% | 16,41% | 3,48% | 7,7% | 5,67% | -8,76% | 9,63% | 1,62% | -5,62% | 4,42% | -0,43% | 4,79% | 14,7% | 10,47% |
| WPA 2 | 14,49 | 18,89 | - | 83,12 | 36,17 | 45,55 | 81,72 | 32,45 | 38,46 | 70,91 | 50,30 | 11,76 | 62,06 | 2,650 | 6,350 | 9,000 | -7,720 | 11,02 | 3,300 | -4,500 | 3,800 | -0,7000 | 4,500 | 18,60 | 23,10 |
| Dividend per aandeel | 8,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17,00 | 17,00 | - | - | - | - | - | 17,00 |
| Datum van publicatie | 14/05/20 | 10/11/20 | 13/05/21 | 9/11/21 | 10/02/22 | 12/05/22 | 12/05/22 | 4/08/22 | 10/11/22 | 10/11/22 | 9/02/23 | 11/05/23 | 11/05/23 | 8/08/23 | 9/11/23 | 9/11/23 | 14/02/24 | 10/05/24 | 10/05/24 | - | - | - | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Balans
| Fiscaal tijdperk: March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie | - | - | - | - | - | - | - | - |
| Nettokaspositie | 19.146 | 24.852 | 22.586 | 50.875 | 34.448 | - | - | - |
| Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 2.356 | 10.165 | -86 | 30.204 | -11.332 | 8.006 | 1.643 | 3.136 |
| ROE (netto-inkomsten/eigen vermogen) | 5,9% | 13,6% | 23,3% | 15,4% | 1,3% | 3,22% | 3,63% | 4,16% |
| ROA (netto-inkomsten/totale activa) | 8,69% | 17,2% | 27,7% | 16,9% | 2,72% | 5% | - | - |
| Totale activa 1 | 43.939 | 55.546 | 71.651 | 94.806 | 54.431 | 73.160 | - | - |
| Nettoactief per aandeel 2 | 552,0 | 616,0 | 796,0 | 932,0 | 926,0 | 930,0 | 941,0 | 955,0 |
| Cashflow per aandeel 2 | 56,90 | 107,0 | 195,0 | 167,0 | 48,70 | 77,40 | 86,60 | 91,30 |
| Capex 1 | 3.983 | 8.673 | 12.356 | 5.747 | 12.778 | 10.000 | 6.000 | 5.000 |
| Capex/omzet | 11,52% | 18,82% | 18,25% | 7,35% | 29,37% | 21,09% | 11,87% | 9,36% |
| Datum van publicatie | 14/05/20 | 13/05/21 | 12/05/22 | 11/05/23 | 10/05/24 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
3
Laatste slotkoers
1.176
JPY
Gemiddelde koersdoel
1.567
JPY
Spread / Gemiddelde doel
+33,22%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +24,74% | 47,96 mld. | |
| -0,47% | 42,45 mld. | |
| +43,96% | 41,47 mld. | |
| +25,40% | 31,6 mld. | |
| +17,96% | 28,63 mld. | |
| -4,47% | 28,03 mld. | |
| +50,73% | 14,56 mld. | |
| +42,56% | 14,14 mld. | |
| +1,46% | 12,58 mld. |
- Beurs
- Aandelen
- Koers 4974
- Koers TF2
- Financiën Takara Bio Inc.
